ReviewClinical optometry2026
Dry Eye Disease And The Jenvis Dry Eye Report Diagnosis Tool: A Literature Review with Emphasis On African Populations.
Review in Clinical optometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dry Eye Disease (DED) is a multifactorial ocular surface disorder characterized by tear film instability, ocular discomfort, and visual disturbance. Traditional diagnostic methods often show poor correlation with symptoms and lack reproducibility. The JENVIS Pro Dry Eye Report, integrated with the OCULUS Keratograph 5M, provides a structured, non-invasive, and multimodal approach to DED diagnosis in line with TFOS DEWS II recommendations. Aim: To review Dry Eye Disease and evaluate the diagnostic role of the JENVIS Pro Dry Eye Report, with particular emphasis on its application and limited utilization in African populations. Methods: A literature review was conducted using Google Scholar, PubMed, and ScienceDirect, focusing on studies published between 2017 and 2025. Search terms included Dry Eye Disease, JENVIS Pro Dry Eye Report, OCULUS Keratograph 5M, non-invasive diagnostics, and tear film instability. Studies addressing DED epidemiology, risk factors, diagnostic methods, and JENVIS-related parameters such as non-invasive tear break-up time, tear meniscus height, and meibography were included. Results: Seventy sources were reviewed, including peer-reviewed articles and relevant grey literature. The evidence supports the JENVIS Pro Dry Eye Report as a reliable and reproducible diagnostic system that integrates objective clinical signs with subjective symptom assessment. While the tool is widely recognised internationally, its clinical use in African populations remains limited, with most regional studies relying on traditional diagnostic techniques such as Schirmer's test and fluorescein tear break-up time. Conclusion: The JENVIS Pro Dry Eye Report offers a comprehensive and objective approach to DED diagnosis compared with conventional methods. Expanding its application in African clinical settings may improve diagnostic consistency, patient education, and evidence-based management of Dry Eye Disease. Contribution: The study provides background and benefits of the use of JENVIS Dry Eye report in diagnosing DED and advocates for its use due to its benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.